COVID-19 research at UCL
Our experts are urgently researching new ways of tackling the COVID-19 pandemic and are taking a prominent role in advancing public knowledge by advising world leaders, collaborating with key partners and providing expert commentary to inform the media.
Call for participants: Storm Chaser Trial
The research team have just opened a new clinical trial for people who have been exposed to someone with confirmed COVID-19 in the last 8 days. The experimental treatment is with a monoclonol antibody and the trial is being run at the UCLH Clinical Research Facility. It is sponsored by Astrazeneca. The purpose of this trial is to test whether a new drug can prevent or treat COVID-19. Please email the trials team if you are interested in participating: email@example.com or call +44 (0) 203 151 3117.
1 December 2020
Two antiviral drugs are being given to COVID-19 positive adults to establish if they stop the virus replicating, as part of a trial led by UCL scientists.
28 October 2020
UCL engineers and medics who developed a CPAP breathing aid now used in hospitals across the UK have received an award from the Royal Academy of Engineering for exceptional services during a pandemic.
17 August 2020
UCL has launched Virus Watch, inviting 42,500 people to take part in one of the largest and most comprehensive studies of Covid-19 in the UK to study the next phase of the pandemic.
23 June 2020